These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 34916464)
1. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19. Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464 [TBL] [Abstract][Full Text] [Related]
2. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170 [TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses. DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431 [TBL] [Abstract][Full Text] [Related]
5. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142 [TBL] [Abstract][Full Text] [Related]
6. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]
7. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019. Kumari P; Gupta UD; Bhagyawant SS Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459 [TBL] [Abstract][Full Text] [Related]
8. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections. Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ Front Immunol; 2023; 14():980711. PubMed ID: 36875134 [TBL] [Abstract][Full Text] [Related]
9. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115 [TBL] [Abstract][Full Text] [Related]
10. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature. Ręka G; Korzeniowska A; Piecewicz-Szczęsna H Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218 [TBL] [Abstract][Full Text] [Related]
11. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil. Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502 [TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial. Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606 [TBL] [Abstract][Full Text] [Related]
14. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques. White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S Front Immunol; 2021; 12():801799. PubMed ID: 35222355 [TBL] [Abstract][Full Text] [Related]
15. Association between presence of Bacillus Calmette-Guerin vaccine scar and coronavirus disease 2019. Caliskaner Ozturk B; Vardaloglu I; Ongel Harbiyeli D; Gungordu N; Senkardesler G; Aliyeva N; Ismayilova A; Can G; Balkan II; Gemicioglu B; Borekci S Medicine (Baltimore); 2022 Dec; 101(48):e32185. PubMed ID: 36482635 [TBL] [Abstract][Full Text] [Related]
16. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19? Finotti P Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305 [TBL] [Abstract][Full Text] [Related]
17. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/ Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806 [TBL] [Abstract][Full Text] [Related]
18. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial. Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM; mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004 [TBL] [Abstract][Full Text] [Related]
19. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic. Aspatwar A; Gong W; Wang S; Wu X; Parkkila S Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271 [TBL] [Abstract][Full Text] [Related]
20. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]